Research Insight
Research Insight
Medtronic CEO and chairman Omar Ishrak to make a formal presentation on the company at CEO Investor Forum 3.0
Medtronic plc , the global leader in medical technology announced it will participate in the CECP CEO Investor Forum 3.0 in New York on Monday, February 26, 2018, at 4:00 p.m. EST.
Omar Ishrak, chairman and chief executive officer of...
Research Insight
Medtronic’s pediatric study: Minimed(TM) 670G shows positive results among children aged 7 to 13
Medtronic plc , the global leader in medical technology announced that new data from its at-home pediatric study of the MiniMed(TM) 670G system in patients 7-13 years of age were presented at the Advanced Technologies & Treatments for Diabetes...
Research Insight
Austin Area Obstetrics, Gynecology and Fertility Completes Successful First Year of Clinical Research
Since it started offering patients the opportunity to participate in clinical research a year ago, Austin Area Obstetrics, Gynecology and Fertility has provided research opportunities to more than 100 patients, announced Jinous Rouhani, practice CEO.
The top-rated obstetrics and gynecology...
Research Insight
Compound designed to fight Alzheimer’s disease shows promise in the lab
The year was 1906, and German physician Alois Alzheimer was examining the brain of a patient who had died after a battle with progressive dementia.
The woman had experienced memory loss and other psychological changes. Alzheimer noticed the accumulation of...
Research Insight
Long-term protection against HIV : Gene therapy using CAR T cells
A UCLA-led research team has created blood-forming stem cells that can carry a gene that allows the body to produce cells that can detect and destroy HIV-infected cells. The blood-forming cells, called hematopoietic stem and progenitor cells, or HSPCs,...
Research Insight
Phase 3 PROSPER Trial Shows XTANDI Significantly Reduced the Risk of Metastasis or Death by 71 Percent in Men with Non-Metastatic Castration-Resistant Prostate Cancer
Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) and Pfizer Inc. (NYSE: PFE) announced today results from the Phase 3 PROSPER trial in patients with non-metastatic (M0) Castration-Resistant Prostate Cancer (CRPC).
The results show that the use...
Research Insight
Leading Advances in Transplant Medicine
NYU Langone has assembled a team dedicated to cutting-edge research, to reinforce and energize the Transplant Institute’s commitment to world-class care. Dr. Kon, who comes to NYU Langone from the University of Maryland Medical Center, brings significant research experience...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read